이뮤즈테라퓨틱스

About IMMUSE Therapeutics

Overview

Our company is composed of personnel with experience and expertise in the entire drug development cycle,
and based on this, we aim to develop innovative immuno-anticancer drugs.

In particular, we are developing various target-based drugs that induce the control of the tumor microenvironment and the functional recovery of cytotoxic T cells, which are major factors that cause the problems of existing immune checkpoint inhibitors (low reactivity and drug resistance).


go top